Cite
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
MLA
Tomida, Ryotaro, et al. “Impact of Carcinoma in Situ on the Outcome of Intravesical Bacillus Calmette-Guérin Therapy for Non-Muscle-Invasive Bladder Cancer: A Comparative Analysis of Large Real-World Data.” International Journal of Clinical Oncology, vol. 27, no. 5, May 2022, pp. 958–68. EBSCOhost, https://doi.org/10.1007/s10147-022-02127-7.
APA
Tomida, R., Miyake, M., Minato, R., Sawada, Y., Matsumura, M., Iida, K., Hori, S., Fukui, S., Ohyama, C., Miyake, H., Hongo, F., Taoka, R., Kobayashi, T., Kojima, T., Matsui, Y., Nishiyama, N., Kitamura, H., Nishiyama, H., Fujimoto, K., & Hashine, K. (2022). Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data. International Journal of Clinical Oncology, 27(5), 958–968. https://doi.org/10.1007/s10147-022-02127-7
Chicago
Tomida, Ryotaro, Makito Miyake, Ryoei Minato, Yuichiro Sawada, Masafumi Matsumura, Kota Iida, Shunta Hori, et al. 2022. “Impact of Carcinoma in Situ on the Outcome of Intravesical Bacillus Calmette-Guérin Therapy for Non-Muscle-Invasive Bladder Cancer: A Comparative Analysis of Large Real-World Data.” International Journal of Clinical Oncology 27 (5): 958–68. doi:10.1007/s10147-022-02127-7.